Nebulized Versus Intravenous Tranexamic Acid on Surgical Field Quality in Patients Undergoing Endoscopic Sinus Surgeries

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 18, 2025

Primary Completion Date

June 15, 2025

Study Completion Date

July 1, 2025

Conditions
NebulizationIntravenousSurgical FieldEndoscopic Sinus Surgeries
Interventions
DRUG

nebulized tranexamic acid

patients will receive a preoperative nebulizer session of 500 mg of tranexamic acid. To ensure the blinding of the participating anesthetist and patient, patients in this group will receive an intravenous drip of 100 ml of 0.9% normal saline.

DRUG

intravenous tranexamic acid

patients will receive a preoperative intravenous drip of TXA at a dose of 15 mg/kg in 100 ml of normal saline. To ensure blinding this group patients will receive 5 ml of 0.9% normal saline nebulizer session.

Trial Locations (1)

Unknown

RECRUITING

Faculty of Medicine, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER